BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Di R, Yang C, Zhao C, Yuan F, Qiao Q, Gu J, Li X, Xu Y, Yang Y. Identification and functional characterization of KLF5 as a novel disease gene responsible for familial dilated cardiomyopathy. European Journal of Medical Genetics 2020;63:103827. [DOI: 10.1016/j.ejmg.2019.103827] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Santoyo-suarez MG, Mares-montemayor JD, Padilla-rivas GR, Delgado-gallegos JL, Quiroz-reyes AG, Roacho-perez JA, Benitez-chao DF, Garza-ocañas L, Arevalo-martinez G, Garza-treviño EN, Islas JF. The Involvement of Krüppel-like Factors in Cardiovascular Diseases. Life 2023;13:420. [DOI: 10.3390/life13020420] [Reference Citation Analysis]
2 Guo Y, Wang J, Guo X, Gao R, Yang C, Li L, Sun Y, Qiu X, Xu Y, Yang Y. KLF13 Loss‐of‐Function Mutations Underlying Familial Dilated Cardiomyopathy. JAHA 2022. [DOI: 10.1161/jaha.122.027578] [Reference Citation Analysis]
3 Kucher AN, Sleptcov AA, Nazarenko MS. Genetic Landscape of Dilated Cardiomyopathy. Russ J Genet 2022;58:369-83. [DOI: 10.1134/s1022795422030085] [Reference Citation Analysis]
4 Wang Z, Qiao X, Xu Y, Liu X, Huang R, Xue S, Qiu H, Yang Y, Aga SS. SMAD1 Loss-of-Function Variant Responsible for Congenital Heart Disease. BioMed Research International 2022;2022:1-8. [DOI: 10.1155/2022/9916325] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Palioura D, Lazou A, Drosatos K. Krüppel-like factor (KLF)5: An emerging foe of cardiovascular health. J Mol Cell Cardiol 2022;163:56-66. [PMID: 34653523 DOI: 10.1016/j.yjmcc.2021.10.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
6 Ataklte F, Vasan RS. Heart failure risk estimation based on novel biomarkers. Expert Rev Mol Diagn 2021;21:655-72. [PMID: 34014781 DOI: 10.1080/14737159.2021.1933446] [Reference Citation Analysis]
7 Zhao L, Jiang WF, Yang CX, Qiao Q, Xu YJ, Shi HY, Qiu XB, Wu SH, Yang YQ. SOX17 loss-of-function variation underlying familial congenital heart disease. Eur J Med Genet 2021;64:104211. [PMID: 33794346 DOI: 10.1016/j.ejmg.2021.104211] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
8 Hua TR, Zhang SY. Cardiomyopathies in China: A 2018-2019 state-of-the-art review. Chronic Dis Transl Med 2020;6:224-38. [PMID: 33336168 DOI: 10.1016/j.cdtm.2020.05.006] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
9 Qiao Q, Zhao CM, Yang CX, Gu JN, Guo YH, Zhang M, Li RG, Qiu XB, Xu YJ, Yang YQ. Detection and functional characterization of a novel MEF2A variation responsible for familial dilated cardiomyopathy. Clin Chem Lab Med 2021;59:955-63. [PMID: 33554560 DOI: 10.1515/cclm-2020-1318] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
10 Wu SH, Wang XH, Xu YJ, Gu JN, Yang CX, Qiao Q, Guo XJ, Guo YH, Qiu XB, Jiang WF, Yang YQ. ISL1 loss-of-function variation causes familial atrial fibrillation. Eur J Med Genet 2020;63:104029. [PMID: 32771629 DOI: 10.1016/j.ejmg.2020.104029] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]